T2 Biosystems, Inc (TTOO): רווח נקי למניה (EPS TTM)
T2 Biosystems, Inc. (TTOO) management is maintaining steady growth despite margin pressure during scaling. The rolling unit profit metric illustrates the results of implementing proprietary T2MR systems for rapid sepsis diagnostics. This trend is driven by hospital adoption of the technology and insurance reimbursements, while -0.03 serves as the current metric value determining the business's present fundamental value.
פילוחים אנליטיים ודוחות נתונים של חברת T2 Biosystems Inc. (TTOO)
To build a high-quality portfolio, I use EPS TTM as a filter for real business efficiency. This metric is calculated by dividing the total net income over the last four quarters by the total number of shares. For T2 Biosystems, Inc. (TTOO), this calculation reflects the conversion of sepsis diagnostic system sales into actual shareholder income. By analyzing the earnings per share over a rolling year, an investor determines the sustainability of the cartridge monetization model. The trend along this curve allows for the timely detection of systemic financial drawdowns.
